After more than 15 years of setbacks, Mesoblast has finally secured its first FDA approval, and early signs suggest the ... Read More The post Dr Boreham’s Crucible: The long grind finally pays off ...

The CSE opened down yesterday and remained in the red throughout midday trading in the manner of other markets in the region, following US President Donald Trump’s threat to annihilate Iran’s energy ...

APN Resources (LON:APN) executives said the company delivered strong first-half FY2026 growth and entered the second half with “great momentum,” while maintaining full-year revenue guidance of £140 ...

Indian pharma companies are releasing over 50 generic versions of Ozempic and Wegovy at eye-watering prices of $14 a month.

Major stock markets in Asia slumped on Monday after Washington and Tehran threatened to escalate hostilities, as the Iran war enters its fourth week. Japan’s benchmark Nikkei 225 index was almost 3.6% ...

Global stockout halts access to Hemgenix gene therapy, delaying treatment for adults with hemophilia B amid manufacturing challenges.

Global capability centres (GCCs) in India are moving up the corporate ladder, with nearly 20% of such centres enjoying real ...

PNE Group has completed the sale of its Legnica wind farm project in southwest Poland through its subsidiary PNE Polska, marking another successful transaction in the country’s growing renewable ...